Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis Int J Drug Policy, 2025. PubMed


Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J, 2025. PubMed


Zazoulina J, Nolan S, Fairbairn N, Ryan A, Dennis BB, Bach P Intravenous fentanyl for symptom management in hospitalized patients with refractory opioid withdrawal: a retrospective cohort study J Addict Med, 2025. PubMed


Goodyear T, Barborini C, Gilmore R, Collin-Gray A, Jensen M, Young L, Hossain A, He E, other members of the Substance Use Beyond the Binary Youth Action Committee Harm reduction in photovoice knowledge mobilization with 2S/LGBTQ+ youth who use(d) drugs: a community showcase Harm Reduct J, 2025. PubMed


Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon B, Socías ME Use of buprenorphine/naloxone in an adult with cystic fibrosis Can J Hosp Pharm, 2025. PubMed


Ti L, Mihic T, Beauchesne A, Grant C, Frank I, Haji N, Legal M, Shalansky S, Nolan S Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis Addict Sci Clin Pract, 2025. PubMed


Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada Addiction, 2025. PubMed


Crepeault H, Tobias S, Angelucci J, Dubland S, Lysyshyn M, Wood E, Ti L Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: a validation study Drug Alcohol Depend, 2025. PubMed


Tobias S, Angelucci J, Wood E, Buxton JA, Ti L Novel adulterants in unregulated opioids and their associations with adverse events Can J Public Health, 2025. PubMed


Gallant K, Speed KA, Betsos A, Abele B, Bonn M, Crichlow F, de Kiewit A, Nurse M, Sherstobitoff A, Touesnard N, Turner K, National Working Group of People with Lived and Living Expertise, Boyd J "The people who depended on us became expendable": Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic Harm Reduct J, 2025. PubMed